Annual report
6960.TEDINET S100OJ3B
Period2021-04-01 → 2022-03-31
Filed2022-06-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥132.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥146.8bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥133.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥129.8bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥128.9bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥22.7bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥19.8bn | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥23.4bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥20.3bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥13.6bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.3bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥12.7bn | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥23.7bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥21.0bn | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥16.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥14.7bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥9.6bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.6bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.3bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥16.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥14.7bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥195.5bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥191.8bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥168.7bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥160.9bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥157.5bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥45.6bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥53.8bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥149.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥138.0bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥124.4bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥119.2bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥113.3bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥64.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥56.6bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥61.0bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.6bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥46.1bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥43.8bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥43.4bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥23.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥21.7bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥20.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥14.0bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥17.9bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥10.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥11.3bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥14.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥10.6bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.8bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥4.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.0bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.0bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.8bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥1,072.38 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥973.33 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥633.03 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥629.37 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥612.49 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥9,909.4 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥9,125.88 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥8,229.96 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥7,831.61 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥7,442.43 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 76.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.0% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.1% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.9% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 11.3% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.2% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.9% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.2% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.5% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 3,348 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 3,291 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 3,208 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 3,121 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 3,132 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥82.5bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥81.8bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥71.8bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥71.6bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥71.0bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥12.7bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥11.5bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥18.0bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥15.0bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥9.9bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥12.0bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.6bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥18.5bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥15.8bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥14.4bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥12.0bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥8.0bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥9.5bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥8.9bn | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥163.5bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥158.1bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥137.3bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥131.4bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥127.8bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥46.5bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥50.9bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥117.1bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥107.2bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥96.7bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥92.8bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥86.8bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥41.3bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥33.3bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥955.2 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥794.03 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥529.6 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥625.9 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥584.21 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥305 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥275 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥175 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥170 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥7,742.42 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥7,087.89 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥6,398.56 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥6,096.47 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥5,702.49 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 71.6% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.8% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.4% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.6% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.9% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 12.9% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.8% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.6% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.7% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 19,588,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 19,588,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 19,588,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 19,588,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 19,588,000 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 669 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 659 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 651 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 629 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 650 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 64
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥93.5bn |
| Consumables And Other Productsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥1.8bn |
| Consumables And Other Productsreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥593m |
| Consumables And Other Productsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥35.2bn |
| Consumables And Other Productsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥35.2bn |
| Consumables And Other Productsreportable segment | segment assets | at 2022-03-31 | ¥24.1bn |
| Consumables And Other Productsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥5.1bn |
| Medical Treatment Equipmentreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥10.4bn |
| Medical Treatment Equipmentreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥7.7bn |
| Medical Treatment Equipmentreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥54.6bn |
| Medical Treatment Equipmentreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥54.6bn |
| Medical Treatment Equipmentreportable segment | segment assets | at 2022-03-31 | ¥48.1bn |
| Medical Treatment Equipmentreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥11.5bn |
| Patient Monitoring Equipmentreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥655m |
| Patient Monitoring Equipmentreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥217m |
| Patient Monitoring Equipmentreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥12.9bn |
| Patient Monitoring Equipmentreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥12.9bn |
| Patient Monitoring Equipmentreportable segment | segment assets | at 2022-03-31 | ¥9.9bn |
| Patient Monitoring Equipmentreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥2.0bn |
| Physiological Diagnostic Equipmentreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥1.5bn |
| Physiological Diagnostic Equipmentreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥495m |
| Physiological Diagnostic Equipmentreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥29.4bn |
| Physiological Diagnostic Equipmentreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥29.4bn |
| Physiological Diagnostic Equipmentreportable segment | segment assets | at 2022-03-31 | ¥19.9bn |
| Physiological Diagnostic Equipmentreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥4.1bn |
| —segment total | employees | at 2022-03-31 | 2650 pure |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥14.3bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥9.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥132.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥132.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥102.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥22.7bn |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥88.7bn |
| Consumables And Other Productsreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥1.6bn |
| Consumables And Other Productsreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥495m |
| Consumables And Other Productsreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥37.0bn |
| Consumables And Other Productsreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥37.0bn |
| Consumables And Other Productsreportable segment | segment assets | at 2021-03-31 | ¥22.5bn |
| Consumables And Other Productsreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥4.5bn |
| Medical Treatment Equipmentreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥9.3bn |
| Medical Treatment Equipmentreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥7.1bn |
| Medical Treatment Equipmentreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥55.2bn |
| Medical Treatment Equipmentreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥55.2bn |
| Medical Treatment Equipmentreportable segment | segment assets | at 2021-03-31 | ¥45.8bn |
| Medical Treatment Equipmentreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥10.2bn |
| Patient Monitoring Equipmentreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥604m |
| Patient Monitoring Equipmentreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥188m |
| Patient Monitoring Equipmentreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥14.1bn |
| Patient Monitoring Equipmentreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥14.1bn |
| Patient Monitoring Equipmentreportable segment | segment assets | at 2021-03-31 | ¥9.5bn |
| Patient Monitoring Equipmentreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥1.8bn |
| Physiological Diagnostic Equipmentreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥1.7bn |
| Physiological Diagnostic Equipmentreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥542m |
| Physiological Diagnostic Equipmentreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥40.4bn |
| Physiological Diagnostic Equipmentreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥40.4bn |
| Physiological Diagnostic Equipmentreportable segment | segment assets | at 2021-03-31 | ¥25.2bn |
| Physiological Diagnostic Equipmentreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥3.3bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-04-01 → 2021-03-31 | ¥13.3bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-04-01 → 2021-03-31 | ¥8.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥146.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥146.8bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥103.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥19.8bn |
| —segment total | employees | at 2022-03-31 | 549 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,664
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | CurrentYearInstant | 195495000000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 7442.43 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 7831.61 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 8229.96 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 9125.88 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 9909.40 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 612.49 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 629.37 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 633.03 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 973.33 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 1072.38 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.719 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.741 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.737 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.720 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.767 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | 0.085 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | 0.082 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.079 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.112 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.113 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | 12.8 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | 11.9 | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | 13.3 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 8.6 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 7.3 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | 17852000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | 13979000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | 20233000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 21743000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 23111000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | -3780000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -10648000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -14170000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -11267000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -10789000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | -2756000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | -2984000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | -3713000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -3046000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | -4832000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 43357000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 43824000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant | 46085000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 53564000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |